CorMedix Inc (NASDAQ:CRMD) shares, rose in value on Thursday, March 27, with the stock price down by -6.28% to the previous day’s close as strong demand from buyers drove the stock to $6.71.
Actively observing the price movement in the last trading, the stock closed the session at $7.16, falling within a range of $6.64 and $7.11. The value of beta (5-year monthly) was 1.529. Referring to stock’s 52-week performance, its high was $13.85, and the low was $3.61. On the whole, CRMD has fluctuated by -36.34% over the past month.
With the market capitalization of CorMedix Inc currently standing at about $407.14 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-24.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 124.85M, with a low estimate of 29.08M and a high estimate of 33.18M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 32.2M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CRMD’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of CRMD currently trading nearly -32.52% and -36.60% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 24.90, while the 7-day volatility ratio is showing 11.66% which for the 30-day chart, stands at 7.57%. Furthermore, CorMedix Inc (CRMD)’s beta value is 1.50, and its average true range (ATR) is 0.80.
A comparison of CorMedix Inc (CRMD) with its peers suggests the former has fared considerably weaker in the market. CRMD showed an intraday change of -6.28% in last session, and over the past year, it grew by 64.46%%.
Data on historical trading for CorMedix Inc (NASDAQ:CRMD) indicates that the trading volumes over the past 10 days have averaged 3.05 and over the past 3 months, they’ve averaged 1.35 million. According to company’s latest data on outstanding shares, there are 64.41 million shares outstanding.
Nearly 2.35% of CorMedix Inc’s shares belong to company insiders and institutional investors own 37.73% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 8.18 million shares as on 2025-03-14, resulting in a short ratio of 10.23. According to the data, the short interest in CorMedix Inc (CRMD) stood at 1349.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 7.39 million. The stock has fallen by -17.16% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CRMD stock heading into the next quarter.
